• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

相似文献

1
Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.成人异基因造血干细胞移植患者应用静脉注射喷他脒预防卡氏肺孢子菌肺炎。
Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0083322. doi: 10.1128/aac.00833-22. Epub 2022 Oct 10.
2
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.回顾性分析异基因造血干细胞移植中静脉注射喷他脒预防肺孢子菌肺炎的效果
Transpl Infect Dis. 2016 Feb;18(1):63-9. doi: 10.1111/tid.12486. Epub 2016 Jan 30.
3
Variance in Pneumocystis jirovecii prophylaxis practice for pediatric patients undergoing hematopoietic cell transplantation.小儿造血细胞移植患者中预防卡氏肺孢子菌感染的实践存在差异。
Pediatr Blood Cancer. 2024 Oct;71(10):e31201. doi: 10.1002/pbc.31201. Epub 2024 Jul 15.
4
A retrospective study of intravenous pentamidine for Pneumocystis jirovecii pneumonia prophylaxis in adult patients with hematologic malignancies-its utility during respiratory virus pandemics.一项回顾性研究表明，静脉注射喷他脒可预防血液系统恶性肿瘤成人患者发生卡氏肺孢子虫肺炎——在呼吸道病毒大流行期间具有一定的应用价值。
Int J Infect Dis. 2024 Jun;143:107059. doi: 10.1016/j.ijid.2024.107059. Epub 2024 Apr 16.
5
Effectiveness and tolerability of intravenous pentamidine for Pneumocystis carinii pneumonia prophylaxis in adult hematopoietic stem cell transplant patients: a retrospective study.静脉注射喷他脒预防成人造血干细胞移植患者卡氏肺孢子虫肺炎的有效性和耐受性：一项回顾性研究。
BMC Infect Dis. 2020 Jun 5;20(1):400. doi: 10.1186/s12879-020-05127-y.
6
High incidence of Pneumocystis jirovecii pneumonia in allogeneic hematopoietic cell transplant recipients in the modern era.在现代，异基因造血细胞移植受者中肺孢子菌肺炎的发病率很高。
Cytotherapy. 2020 Jan;22(1):27-34. doi: 10.1016/j.jcyt.2019.11.002. Epub 2019 Dec 27.
7
Pentamidine for Prophylaxis against Pneumocystis jirovecii Pneumonia in Pediatric Oncology Patients Receiving Immunosuppressive Chemotherapy.喷他脒预防接受免疫抑制化疗的儿科肿瘤患者发生肺孢子菌肺炎。
Antimicrob Agents Chemother. 2018 Jul 27;62(8). doi: 10.1128/AAC.00173-18. Print 2018 Aug.
8
Efficacies of atovaquone, pentamidine, and trimethoprim/sulfamethoxazole for the prevention of Pneumocystis jirovecii pneumonia in patients with connective tissue diseases.阿托伐醌、喷他脒和甲氧苄啶/磺胺甲恶唑对结缔组织病患者预防耶氏肺孢子菌肺炎的疗效。
J Infect Chemother. 2019 May;25(5):351-354. doi: 10.1016/j.jiac.2019.01.005. Epub 2019 Jan 31.
9
Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipients.氨苯砜在血液病患者中的安全性：优化血液系统恶性肿瘤和移植受者预防耶氏肺孢子菌肺炎的途径。
Transpl Infect Dis. 2018 Dec;20(6):e12968. doi: 10.1111/tid.12968. Epub 2018 Aug 4.
10
A prospective study of intravenous pentamidine for PJP prophylaxis in adult patients undergoing intensive chemotherapy or hematopoietic stem cell transplant.一项前瞻性研究，评估静脉注射喷他脒用于接受强化化疗或造血干细胞移植的成年患者中预防卡氏肺孢子虫肺炎（PJP）的效果。
Bone Marrow Transplant. 2018 Mar;53(3):300-306. doi: 10.1038/s41409-017-0024-1. Epub 2017 Dec 21.

引用本文的文献

1
Incidence of Pneumonia in Immunocompromised Patients without Human Immunodeficiency Virus on Intravenous Pentamidine Prophylaxis: A Systematic Review and Meta-Analysis.接受静脉注射喷他脒预防的无人类免疫缺陷病毒免疫功能低下患者肺炎的发病率：一项系统评价和荟萃分析
J Fungi (Basel). 2023 Mar 25;9(4):406. doi: 10.3390/jof9040406.

本文引用的文献

1
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients.欧洲癌症研究与治疗组织血液病/造血干细胞移植患者肺孢子菌肺炎预防指南。
J Antimicrob Chemother. 2016 Sep;71(9):2397-404. doi: 10.1093/jac/dkw157. Epub 2016 May 12.
2
Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.《癌症相关感染的预防和治疗》，第 2.2016 版，NCCN 肿瘤学临床实践指南。
J Natl Compr Canc Netw. 2016 Jul;14(7):882-913. doi: 10.6004/jnccn.2016.0093.
3
The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis.造血细胞移植后耶氏肺孢子菌肺炎的发病率、死亡率及发病时间：一项国际骨髓移植登记处（CIBMTR）分析
Bone Marrow Transplant. 2016 Apr;51(4):573-80. doi: 10.1038/bmt.2015.316. Epub 2016 Jan 4.
4
Retrospective review of intravenous pentamidine for Pneumocystis pneumonia prophylaxis in allogeneic hematopoietic stem cell transplantation.回顾性分析异基因造血干细胞移植中静脉注射喷他脒预防肺孢子菌肺炎的效果
Transpl Infect Dis. 2016 Feb;18(1):63-9. doi: 10.1111/tid.12486. Epub 2016 Jan 30.
5
IV pentamidine for primary PJP prophylaxis in adults undergoing allogeneic hematopoietic progenitor cell transplant.对于接受异基因造血祖细胞移植的成人，静脉注射喷他脒用于原发性肺孢子菌肺炎预防。
Bone Marrow Transplant. 2015 Sep;50(9):1253-5. doi: 10.1038/bmt.2015.131. Epub 2015 Jun 8.
6
Intravenous pentamidine for Pneumocystis carinii/jiroveci pneumonia prophylaxis in pediatric transplant patients.静脉注射喷他脒用于儿童移植患者卡氏肺孢子虫/耶氏肺孢子虫肺炎的预防
Pediatr Transplant. 2015 May;19(3):326-31. doi: 10.1111/petr.12441. Epub 2015 Feb 25.
7
Intravenous pentamidine is safe and effective as primary pneumocystis pneumonia prophylaxis in children and adolescents undergoing hematopoietic stem cell transplantation.静脉注射喷他脒作为儿童和青少年造血干细胞移植后原发性肺孢子菌肺炎的预防措施是安全有效的。
Pediatr Infect Dis J. 2013 Sep;32(9):933-6. doi: 10.1097/INF.0b013e318292f560.
8
Pneumocystis jirovecii pneumonia in non-HIV-infected patients in the era of novel immunosuppressive therapies.新型免疫抑制疗法时代非 HIV 感染患者中的卡氏肺孢子菌肺炎。
J Infect Chemother. 2012 Dec;18(6):793-806. doi: 10.1007/s10156-012-0453-0. Epub 2012 Aug 6.
9
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.造血细胞移植受者感染并发症预防指南：全球视角
Biol Blood Marrow Transplant. 2009 Oct;15(10):1143-238. doi: 10.1016/j.bbmt.2009.06.019.
10
Intravenous pentamidine is effective as second line Pneumocystis pneumonia prophylaxis in pediatric oncology patients.静脉注射喷他脒对儿科肿瘤患者预防卡氏肺孢子虫肺炎有二线治疗效果。
Pediatr Blood Cancer. 2008 Apr;50(4):779-83. doi: 10.1002/pbc.21287.

成人异基因造血干细胞移植患者应用静脉注射喷他脒预防卡氏肺孢子菌肺炎。

Pneumocystis jirovecii Pneumonia Prophylaxis with Intravenous Pentamidine in Adult Allogeneic Hematopoietic Stem Cell Transplant Patients.

机构信息

Oregon Health and Science University Hospitals and Clinics, Portland, Oregon, USA.

出版信息

Antimicrob Agents Chemother. 2022 Nov 15;66(11):e0083322. doi: 10.1128/aac.00833-22. Epub 2022 Oct 10.

DOI:10.1128/aac.00833-22
PMID:36214573
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9664864/
Abstract

The purpose of this single-center retrospective case series was to evaluate the efficacy and safety of 300-mg once-monthly intravenous (IV) pentamidine prophylaxis in 702 adult allogeneic hematopoietic stem cell transplant (HSCT) patients. We observed no cases of Pneumocystis jirovecii pneumonia (PJP) following IV pentamidine administration. Breakthrough and infections were observed in 7 (1%) and 5 (0.7%) patients, respectively. The most commonly reported adverse event was nausea. Monthly IV pentamidine is a reasonable alternative to trimethoprim-sulfamethoxazole (TMP-SMX).

摘要

本单中心回顾性病例系列研究的目的是评估 702 例异基因造血干细胞移植（HSCT）成人患者中 300mg 每月一次静脉注射（IV）戊烷脒预防的疗效和安全性。我们在 IV 戊烷脒给药后没有观察到耶氏肺孢子菌肺炎（PJP）的病例。分别有 7 例（1%）和 5 例（0.7%）患者出现突破性感染和感染。最常见的不良事件是恶心。每月一次 IV 戊烷脒是替代甲氧苄啶-磺胺甲恶唑（TMP-SMX）的合理选择。